Canan Özlü

Dr. Canan Özlü

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2024 in Children
Verified
Journal Article
Open access
PDF file
MNMerve Iseri Nepesov
Merve Iseri Nepesov
ÖKÖmer Kılıç
Ömer Kılıç
ESEnes Sali
Enes Sali
EYEdanur Yesil
Edanur Yesil
AAAsuman Akar
Asuman Akar
Ener Cagri DinleyiciEner Cagri Dinleyici
Ener Cagri Dinleyici
Objectives: Septic arthritis (SA) is a serious bacterial infection that must be treated efficiently and timely. The large number of culture-negative cases makes local epidemiological data important. Accordingly, this study aimed to evaluate the etiology, clinical characteristics, and therapeutic approach of SA in children in Turkiye, emphasizing the role of real-time polymerase chain reaction (PCR) techniques in the diagnosis. Methods: In this multi-center, prospective study, children hospitalized due to SA between February 2018 and July 2020 in 23 hospitals in 14 cities in Turkiye were included. Clinical, demographic, laboratory, and radiological findings were assessed, and real-time PCR was performed using synovial fluid samples. Results: Seventy-five children aged between 3 and 204 months diagnosed with acute SA were enrolled. Joint pain was the main complaint at admission, and the most commonly involved joints were the knees in 58 patients (77.4%). The combination of synovial fluid culture and real-time PCR detected causative bacteria in 33 patients (44%). In 14 (18.7%) patients, the etiological agent was demonstrated using only PCR. The most commonly isolated etiologic agent was Staphylococcus aureus, which was detected in 22 (29.3%) patients, while Streptococcus pyogenes was found in 4 (5.3%) patients and Kingella kingae in 3 (4%) patients. Streptococcus pyogenes and Kingella kingae were detected using only PCR. Most patients (81.3%) received combination therapy with multiple agents, and the most commonly used combination was glycopeptides plus third-generation cephalosporin. Conclusions: Staphylococcus aureus is the main pathogen in pediatric SA, and with the use of advanced diagnostic approaches, such as real-time PCR, the chance of diagnosis increases, especially in cases due to Kingella kingae and Streptococcus pyogenes.

15 October 2020 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
NŞNihan Şık
Nihan Şık
CÖCanan Özlü
Canan Özlü
HAHatice Karaoğlu Asrak
Hatice Karaoğlu Asrak
İEİrem Ceren Erbaş
İrem Ceren Erbaş
AGAyşe Çakıl Güzin
Ayşe Çakıl Güzin
MDMurat Duman
Murat Duman
In December 2019, a previously unknown type of coronavirus was detected in China and named as "severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)". The World Health Organization has named the SARS-CoV-2 related as coronavirus disease-2019 (COVID-19) and declared it as a pandemic. There is a limited data about the COVID-19 disease for the pediatric patients. In this study, it was aimed to evaluate the epidemiological, clinical, laboratory and radiologic findings, treatment and clinical outcomes of patients admitted to the pediatric emergency department with the suspicion of COVID-19. Between March 11 and dune 16, 2020, patients aged between 1 month-18 years admitted to the pediatric emergency department and who have an indication for sampling for the polymerase chain reaction (PCR) method with the suspicion of COVID-19 according to the current guidelines published by the Ministry of Health were included in the study. The demographic characteristics, symptoms, durations and the history of contact with the suspected/definite COVID-19 cases were questioned in the patients with positive results. Physical examination, laboratory and imaging data of the patients were recorded. According to clinical severity, patients were divided into five groups. Treatment methods, ward/intensive care unit admission, length of stay at hospital, and prognosis were recorded. Of the 237 patients included in the study, 45 (18.9%) of the samples were positive and 192 (81.1%) were negative. There was a history of contact with COVID-19 positive case in 38 (85.6%) of COVID-19 PCR positive patients. The mean time for onset of symptoms after contact was 3.5 +/- 1.7 days. Twenty-one of the patients (46.6%) were asymptomatic and the most common symptom was fever (34.1%) and cough (27.3%). Of the patients whose laboratory tests were requested, lymphopenia wasdetected in 50% and 52.3% of procalcitonin, 23.5% of C-reactive protein and 64.7% of D-dimer values were found to be high. Chest radiography was obtained from 45.4% of the patients; 90.0% were evaluated as normal, bronchovascular change, pleural effusion and consolidation were detected in one of each (5.0%) patient. Thorax computed tomography (CT) was obtained from 4 (9.0%) patients. One patient had normal CT findings, two patients had consolidation, one patient had peripheral ground-glass appearance and one patient had pleural effusion. Antibiotics were started in 38.6% of the patients and the most commonly used antibiotic was azithromycin (34.1%). Oseltamivir was started in one (2.3%) patient, and 10 (24.7%) patients were treated with hydroxychloroquine. There were no serious and critical cases according to the clinical severity. Pediatric patients constitute a small part of COVID-19 individuals in the community, and a significant part of them are asymptomatic, and patients who are symptomatic present with a mild clinic. In our study, most of the patients had a history of contact with COVID-19 positive cases, therefore, it should be questioned when evaluating a pediatric patient. There were no specific findings for COVID-19 positive patients in terms of laboratory and radiology.

25 December 2021 in The Turkish Journal of Pediatrics
Verified
Journal Article
Closed access
CÖCanan Özlü
Canan Özlü
STSerkan Türkuçar
Serkan Türkuçar
HAHatice Karaoğlu Asrak
Hatice Karaoğlu Asrak
HDHatice Adıgüzel Dündar
Hatice Adıgüzel Dündar
ŞÜŞevket Erbil Ünsal
Şevket Erbil Ünsal
NBNurşen Belet
Nurşen Belet
Background. The widespread use of biological treatments has increased the frequency of opportunistic infections such as tuberculosis (TB). The primary objective of our study was to determine the rate of tuberculin skin test (TST) conversion during biological therapy. The secondary objective was to monitor the side effects related to isoniazid (INH) prophylaxis, in the selected subgroup. Methods. Children with rheumatologic diseases receiving treatment with tumor necrosis factor-alpha (TNF-alpha) inhibitors, and tocilizumab and canakinumab were included in the study. If baseline screening was negative, TST was performed annually after initiation of biologic therapy. TST conversion was accepted as an increase of at least 6 mm and becoming positive or an increase of 10 mm or more, even in the absence of positivity. Results. 121 patients (female n: 63, 52%) were included in the study. The mean follow-up period was 26.10 +/- 14.8 months. 85 of the patients were using TNF-alpha inhibitors and 18 tocilizumab, and 18 canakinumab. Forty patients had positive TST before biological agents and received chemoprophylaxis with INH. The rate of TST conversion among the 3 biological agents was not statistically significant (20.4% of TNF-alpha inhibitors, 25% of canakinumab and 33.3% of tocilizumab users). All patients with LTBI received INH prophylaxis, and none of them had active TB. Conclusions. There was no statistically significant difference among the three biological agents, regarding the seroconversion rates. Patients receiving tocilizumab and canakinumab should also be screened for TB during follow-up. INH related side effects are rare.

15 July 2026 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SDSevliya Ocal Demir
Sevliya Ocal Demir
PEPınar Canizci Erdemli
Pınar Canizci Erdemli
ETEsra Cakmak Taskin
Esra Cakmak Taskin
AYAyşe Tekin Yılmaz
Ayşe Tekin Yılmaz
SSSemra Sen
Semra Sen
GAGülşen Akkoç
Gülşen Akkoç

1 September 2022 in Journal of Pediatric Infection
Verified
Journal Article
Closed access
HAHatice Karaoğlu Asrak
Hatice Karaoğlu Asrak
CÖCanan Özlü
Canan Özlü
İEİrem Ceren Erbaş
İrem Ceren Erbaş
AGAyşe Çakıl Güzin
Ayşe Çakıl Güzin
SASilem OZDEM ALATAŞ
Silem OZDEM ALATAŞ
NBNurşen Belet
Nurşen Belet

19 February 2024 in Journal of Pediatric Infection
Verified
Journal Article
Closed access
TÇTaylan Çelik
Taylan Çelik
KAKamile Ötüken Arıkan
Kamile Ötüken Arıkan
EAEmin Sami Arısoy
Emin Sami Arısoy
BBBurcu Bursal
Burcu Bursal
EEEmine Hafize Erdeniz
Emine Hafize Erdeniz
AKAteş Kara
Ateş Kara